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+
Objectives 
n  Understand CDC screening guidelines for this population 
n  Analyze the importance of screening for anal cancer and 
possibly anal dysplasia 
n  Learn specific risks related to WSW sexual health 
n  Summarize screening guidelines for trans* identified people 
n  Recognize health disparities to target screening and health 
promotion counseling 
+
Taking a comprehensive history 
 
n Use inclusive, gender-neutral language 
n Avoid assumptions 
n Avoid using identity or labeling terms 
n Be welcoming and affirming 
n Show respect and empathy 
+
Taking a sexual history 
n Behavior 
n  “Have you been involved with anyone during the past year 
including oral, vaginal, anal sex or other kinds of sexual 
practices? 
n  “Have you ever been sexually involved with men, women, 
or both?” 
n  “How many sexual partners have you had in the past year?” 
n Identity 
n  “Do you have any concerns about your sexual identity?” 
n Desire 
n  “Do you desire to be involved sexually with men, women, 
or both?” 
+MSM CDC Screening Recommendations 
n Annually 
n  HIV 
n  Syphilis 
n  Gonorrhea 
n  Urethral (urine), rectal, pharyngeal 
n  Chlamydia 
n  Urethral (urine), rectal 
n  Increase screening intervals to 3-6 months if: 
n  Multiple partners 
n  Anonymous partners 
n  Illicit drug use (methamphetamines, poppers, etc) 
CDC Sexually Transmitted Diseases, Treatment Guidelines, 2010: http://www.cdc.gov/std/treatment/2010/specialpops.htm 
+MSM CDC Screening Recommendations 
n Hepatitis A 
n Hepatitis B 
n Hepatitis C  
n  If history of drug use 
n Anal Dysplasia 
+
HIV Negative MSM and Anal Cancer 
n Rates of anal HPV is 60% (compared to 36% in 
heterosexual men) 
n 20x more likely than heterosexual men to be 
diagnosed with anal cancer 
n Rates of anal cancer similar to that of cervical cancer 
in women prior to pap smears (37/100,000) 
n  Increasing age does not decrease rates of anal HPV 
Palefsky J.  The Path To Anal Cancer Prevention: Where We Are and Where We’re Going.  PRN Notebook 2011.  http://
www.prn.org/index.php/coinfections/article/the_path_to_anal_cancer_prevention_1444 
 
+
HIV Positive MSM and Anal Cancer 
n Rates of anal HPV is 90%  
n 40x more likely than heterosexual men to be 
diagnosed with anal cancer 
n Rates of anal cancer higher than the highest 
incidence of cervical cancer anywhere around the 
world (75-137/100,000) 
n Anti-retroviral therapy does not seem to decrease 
rates of anal cancer 
+ “Guidelines” for Screening for  
Anal Dysplasia/Cancer in MSM 
n  No national or international guidelines 
n  Screen for dysplasia with Anal pap test 
n  Screen for cancer with DRE 
n  HIV negative with risk factors:  
n  MSM > age of 40 
n  Perianal condyloma 
n  Every 2-3 years 
n  HIV positive 
n  Annually 
Palefsky J.  The Path To Anal Cancer Prevention: Where We Are and Where We’re Going.  PRN Notebook 
2011.  http://www.prn.org/index.php/coinfections/article/the_path_to_anal_cancer_prevention_1444 
 
+
Anal Pap Preparation and 
Materials 
n Cytology obtained prior to using lubrication 
n No receptive anal intercourse or enema treatment 
within 24 hours of sampling 
n Dacron (synthetic) Swab 
n Thin Prep pap smear medium 
n Patient side-lying 
NYS Guidelines recommendations on anal pap smears.  July 2007.  http://www.natap.org/
2010/HIV/032510_01.htm 
 
+
Abnormal Anal Pap 
n Results analogous to cervical pap smear 
n  If ASCUS or LSIL or more 
n  Refer for High Resolution Anoscopy with biopsy  
n  Not available at UIHC 
n  Refer to UIHC Colorectal Surgery for surveillance with 
anoscopy and early treatment (resection) of cancer 
n Treatment of AIN 2/3 
n  Not proven to prevent anal cancer = Lack of studies  
n  Infra-red coagulation 
n  85% trichloracetic acid 
n  Topical 1% cidofovir for peri-anal disease 
Palefsky J.  The Path To Anal Cancer Prevention: Where We Are and Where We’re Going.  PRN 
Notebook 2011.  http://www.prn.org/index.php/coinfections/article/
the_path_to_anal_cancer_prevention_1444 
+
MSM Vaccination 
Recommendations 
n HPV (ages 9-26) 
n  78% reduction in any grade anal intraepithelial neoplasia 
n  CDC recommendations for males 11-21  
n  MSM specific recommendation through age 26 
n Hepatitis A 
n  Can perform serology first 
n Hepatitis B 
n  Can perform serology first 
+
WSW Risk Assessment 
•  Do not presume low or no risk based on 
sexual orientation or current behavior 
•  Up to 70% of WSW have had sex with men 
•  Increased rates of anal sex with male partners as 
compared to “straight women” 
+
WSW and STIs 
•  High prevalence of BV among monogamous WSW 
•  Cervical dysplasia 
•  Genital condyloma 
•  HSV-1, HSV-2 
•  Gonorrhea, Chlamydia 
•  Syphilis 
+
Screening for Cancer in Lesbians 
n Increased rates of breast and ovarian cancer 
n  Increased rates of obesity, alcohol, smoking, decreased 
parity and breastfeeding, less likely to have used OCPs 
n  Decreased utilization of cancer preventive services 
n Identical guidelines as for heterosexual women 
n  Breast: mammograms every 1-2 years starting at age 40-50 
n  Ovarian: screening not recommended 
n  Cervical: pap tests every 3 years starting at age 21, every 
five years at age 30 
n  HPV vaccination ages 9-26 
HealthyPeople.gov. Lesbian, gay, bisexual, and transgender health. www.healthypeople.gov/2020 
+
Transgender Women 
n  Breast Cancer screening with mammography 
n  Over the age of 50 with additional risk factors: 
n  Estrogen/progestin use >5 years 
n  Positive family history 
n  BMI > 35 
n  Prostate cancer screening 
n  PSA test is usually falsely low with androgen blockade 
n  May multiply PSA x 1.5-2 and interpret with caution 
n  Consider in high risk patients 
n  Perform a DRE to evaluate the prostate in all transwomen 
n  Pap smears in neovaginas are not indicated 
Center of Excellence for Transgender Health.  General Prevention and Screening. http://
transhealth.ucsf.edu/trans?page=protocol-screening#S2X 
 
+
Transgender Men 
n Breast cancer screening 
n Prior male chest reconstruction 
n  Annual chest wall/axillary exam 
n  Mammograms not indicated 
n Breast reduction only or no history of top surgery 
n  Clinical breast exams and mammograms per usual 
guidelines 
Center of Excellence for Transgender Health.  General Prevention and Screening. http://
transhealth.ucsf.edu/trans?page=protocol-screening#S2X 
+
Transgender Men 
n Cervical Cancer screening 
n  As per guidelines for assigned sex at birth females 
n  Inform pathologist of current or prior testosterone use 
n Endometrial Cancer evaluation 
n  Spontaneous vaginal bleeding with identifiable cause 
evaluated as for post-menopausal bleeding 
n  Consider hysterectomy if >40 years 
+
Prevention Pearls 
n Health disparities 
n  Depression/anxiety/suicide 
n  Youth and transgender persons with highest rates 
n  HIV/STI 
n  MSM and transgender women of color most affected 
n  Obesity 
n  Lesbian and bisexual females 
n  Tobacco, alcohol, substance use 
n  Victimization 
n  Trans* persons  
n  Lack of social support/increased isolation 
n  Elderly LGBTQ persons 
HealthyPeople.gov. Lesbian, gay, bisexual, and transgender health. www.healthypeople.gov/2020 
+
Prevention Pearls 
n Lesbian and Bisexual Women 
n  Diet, exercise, healthy weight 
n  Tobacco and alcohol use 
n  Preventive services for cancer screening 
n  STI, contraception, pre-conception counseling 
n Gay and Bisexual Men 
n  STI risk assessment and safer sex counseling 
n  Mental health  
n  Tobacco, alcohol, substance use  
n  Anal cancer or anal dysplasia screening 
+
Prevention Pearls 
n  Trans* persons 
n  Mental health and suicide  
n  STI/HIV risk assessment  
n  Victimization and IPV  
n  LGBTQ Youth 
n  Bullying 
n  Safety of home and school environment 
n  Reliable housing 
n  LGBTQ Elderly 
n  Support system 
n  Long-term care facilities 
n  DPOA/Living Will  
+
Need more information? 
n LGBT Health Care 
n  National LGBT Health Education Center  
n  http://www.lgbthealtheducation.org 
n  CDC Lesbian, Gay, Bisexual and Transgender Health 
n  http://www.cdc.gov/lgbthealth/ 
n Transgender Health Care 
n  Center of Excellence for Transgender Health 
n  http://transhealth.ucsf.edu 
n  World Professional Association for Transgender Health 
n  http://www.wpath.org 
+
Questions? 
n UIHC LGBTQ Clinic  
n  Tuesdays from 5-8 PM at 
Iowa River Landing  
n  Culturally competent staff  
n  Comprehensive Primary 
Care 
n  www.uihealthcare.org/
lgbt/ 
n  319-384-7444 (option 1) 
n  Ages 10 and above 
including OB care 
n  Health Maintenance 
Exams 
n  Acute visits 
n  Contraception 
n  STI testing and treatment 
n  Hormones 
